Black Diamond Therapeutics (BDTX) Return on Assets (2020 - 2021)

Historic Return on Assets for Black Diamond Therapeutics (BDTX) over the last 2 years, with Q3 2021 value amounting to 0.32%.

  • Black Diamond Therapeutics' Return on Assets fell 1700.0% to 0.32% in Q3 2021 from the same period last year, while for Sep 2021 it was 0.32%, marking a year-over-year decrease of 1700.0%. This contributed to the annual value of 0.27% for FY2020, which is 100.0% up from last year.
  • According to the latest figures from Q3 2021, Black Diamond Therapeutics' Return on Assets is 0.32%, which was down 1700.0% from 0.24% recorded in Q2 2021.
  • Black Diamond Therapeutics' Return on Assets' 5-year high stood at 0.13% during Q2 2020, with a 5-year trough of 0.32% in Q3 2021.